News

Rapidly growing immunotherapy pipeline offers hope of disease-altering therapies.

Peter Huber Kaltemaschinenbau GmbH have been named one of the TOP 100 most innovative middle sized enterprises in Germany.

Collaboration aims to conduct joint research to identify genomic mechanisms responsible for clinical outcomes in hepatocellular carcinoma.

BioFocus will provide hit-to-lead and lead optimization services for a €3.3 million drug discovery program at the University of Bristol.

To make castor a commercially viable crop, Scientists are trying to discover a way to genetically modify the plant so that either the gene that produces the toxin is no longer expressed or the toxin is no longer produced.

Bayer AG lost its fifth straight trial over contaminated U.S. long-grain rice to a Louisiana farmer who claimed the company’s carelessness with its genetically engineered seed caused exports to plunge.

Promising tumor response and median PFS data reported at ASCO lead to new Phase IIb trial.

Agar Scientific chose the RMS' biannual conference & exhibition as the venue to launch their 8th catalogue of accessories for microscopy.

Tests on the products Cognis has already acquired from IMD are already delivering promising results, the company informed.

Unprecedented stem cell treatments providing new hope for children with CP.